Navigation Links
GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
Date:4/21/2009

licensing model that enables our customers to start small, with the option to scale-up and add more users as they derive greater value from the software."

GenConnect can accommodate the full spectrum of storage units used in biobanking, from traditional containers such as freezers and liquid nitrogen tanks, to the space saving, energy-efficient room-temperature storage options provided by GenVault. Stringent QA controls are built into the software for all Project, Subject and Sample-level data entry.

About GenVault

GenVault is a Global provider of cutting-edge technologies, for the acquisition, transportation and storage of biospecimens at ambient temperature, in the dry-state. GenConnect software, used to manage these technologies, can also be used with traditional cryogenic systems to enable mixed-phase sample management.

GenVault's technologies are environmentally friendly, space efficient alternatives to traditional sample storage systems. They reduce the carbon footprint of labs and significantly reduce energy consumption.

GenVault's systems are currently empowering over 150 pharmaceutical companies, medical centers and academic research institutions to sustainably leverage the rapidly growing genomics industry.

For more information, visit http://www.genvault.com/.

Available Topic Expert: For information on the listed expert, click appropriate link.

Dipesh Risal

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87341

CONTACT: Bret Dash, 760-268-5242, bdash@genvault.com.


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
3. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
6. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
7. GenVault Expands Scientific Advisory Board
8. GenVault Corporation Launches GenTegra(TM) DNA
9. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
10. GenVault to Present at the BIOCOM Investor Conference
11. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...3/PRNewswire/--Frost&Sullivan,theGrowthPartner...tingleadershipandinnovationThursday,November19,200...theldinSanAntonio,Texas. ,, (Logo: http://www.n...eHealthcareInnovationAwardsaregiventocompaniesthat...nagementofhealthcare.Suchcompanieshaveshownsuccess...
(Date:11/23/2009)...re-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq:...quiring,developingandcommercializingsignificantpro...odayannouncedthatCraigA.Collard,PresidentandChiefE...atthe21stAnnualPiperJaffrayHealthCareConferenceat3...eHotelinNewYorkCity. ,, Aliveaudioandarchivedwe...
(Date:11/20/2009)...ies have an opportunity to take the lead in two sm...iversity of Valencia (UV), working together with t... fabric of the Spanish biotechnology industry. The...rs have more clout than those in English-speaking ...d plants has been overlooked by the leading countr...
(Date:11/20/2009)...ewswire-FirstCall/ -- Dendreon Corporation (Nasdaq...rug Administration (FDA) provided written acknowle...se Application (BLA) for PROVENGE® (sipuleuce... a Prescription Drug User Fee Act (PDUFA) date of ...reon,s amended BLA. Dendreon is seeking licensure...
Breaking Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...l 25 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...nded March 31, 2008., For the quarter ended March...9 million, or $0.53 per share. This compares to a ... the prior quarter ended December 31, 2007,and $55...er in 2007., For the quarter ended March 31, 2008...
...ntists and Collaborators Publish Study in Science,...bH, the,leading developer of RAFT intervention the...per in Science demonstrating a potential novel str...and other diseases by targeting,discrete sub-compa...nducted,by JADO scientists together with several a...
...lif., April 24 ,Exelixis, Inc. (Nasdaq: EXEL ) an...t and chief executive officer of Exelixis, will pr...ugged Conference at 3:40 p.m. ET/12:40,p.m. PT on ...s updates to,the company,s development pipeline an...ebcast and may be accessed in the Event,Calendar p...
Other Biology Technology:CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 1Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 3Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 1Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...r an important and longstanding question about the...tients have high levels of a brain protein because...ear it from their brains quickly enough? , Resear... (ADRC) at Washington University School of Medicin...ensitive way to monitor the production and clearan...
...ered that a recently identified protein critical f...sm to keep its repairs accurate. , The protein, ... proteins known as DNA polymerases that are vital ...while other DNA-repair proteins insure their accur...ns or accessory molecules, this protein maintains ...
...asbro Children’s Research Center and Brown Medical...atest risk for HIV. Amongst a group of high-risk t... for the disease (those who engaged in the most un...ental health problems. , Prior studies have found ...h mental health issues and other high-risk behavio...
Other Biology News:Production of key Alzheimer's protein monitored for first time in humans 2Production of key Alzheimer's protein monitored for first time in humans 3Unusual mechanism keeps repair protein accurate 2Unusual mechanism keeps repair protein accurate 3New HIV study identifies high-risk subgroups of adolescents 2New HIV study identifies high-risk subgroups of adolescents 3
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Biology Products: